<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="29%"></col>
<col width="19%"></col>
<col width="52%"></col>
<tbody>
<tr>
<td stylecode="Botrule Toprule ">
<paragraph>Drugs that Affect Renal          <br/>Function</paragraph>
</td>
<td colspan="2" stylecode="Botrule Toprule ">
<paragraph>A decline in GFR or tubular secretion, as from ACE inhibitors,          <br/>angiotensin receptor blockers, nonsteroidal anti-inflammatory drugs<br/>[NSAIDs], COX-2 inhibitors may impair the excretion of digoxin.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>Antiarrthymics</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>Dofetilide</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>Concomitant administration with digoxin was associated with a higher rate of torsades de pointes.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule "></td>
<td stylecode="Botrule ">
<paragraph>Sotalol</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>Proarrhythmic events were more common in patients receiving sotalol and digoxin than on either alone; it is not clear whether this represents an interaction or is related to the presence of CHF, a known risk factor for proarrhythmia, in patients receiving digoxin.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule "></td>
<td stylecode="Botrule ">
<paragraph>Dronedarone</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>Sudden death was more common in patients receiving digoxin with dronedarone than on either alone; it is not clear whether this represents an interaction or is related to the presence of advanced heart disease, a known risk factor for sudden death in patients receiving digoxin.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>Parathyroid Hormone<br/>Analog</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>Teriparatide</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>Sporadic case reports have suggested that hypercalcemia may predispose patients to digitalis toxicity. Teriparatide transiently increases serum calcium.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>Thyroid supplement</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>Thyroid</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>Treatment of hypothyroidism in patients taking digoxin may increase the dose requirements of digoxin.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>Sympathomimetics</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>Epinephrine Norepinephrine Dopamine</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>Can increase the risk of cardiac arrhythmias.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>Neuromuscular Blocking<br/>Agents</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>Succinylcholine</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>May cause sudden extrusion of potassium from muscle cells, causing arrhythmias in patients taking digoxin.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>Supplements</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>Calcium</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>If administered rapidly by intravenous route, can produce serious arrhythmias in digitalized patients.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>Beta-adrenergic blockers<br/>and calcium channel<br/>blockers</paragraph>
</td>
<td stylecode="Botrule "></td>
<td stylecode="Botrule ">
<paragraph>Additive effects on AV node conduction can result in bradycardia and advanced or complete heart block.</paragraph>
</td>
</tr>
</tbody>
</table>